The use of levo-carnitine in children with renal disease: A review and a call for future studies

Brook Belay, Nora Esteban-Cruciani, Christine A. Walsh, Frederick J. Kaskel

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation. Carnitine deficiency has been described in various conditions, including chronic kidney disease (CKD) and end stage renal disease (ESRD). The deficiency of this micronutrient is postulated to lead to adverse effects across multiple organ systems. There is a paucity of information on carnitine deficiency and its effects in the pediatric CKD and ESRD populations. Currently, there is no evidence supporting the routine use of carnitine supplementation in children with ESRD. In this article, we review the pathophysiology, pharmacokinetics and the potential effects of levo-carnitine supplementation with a focus on the pediatric CKD and ESRD populations. Finally, potential future directions of research are discussed.

Original languageEnglish (US)
Pages (from-to)308-317
Number of pages10
JournalPediatric Nephrology
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2006

Keywords

  • Anemia
  • Cardiac disease
  • Carnitine deficiency
  • Children
  • Kidney disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Nephrology

Fingerprint Dive into the research topics of 'The use of levo-carnitine in children with renal disease: A review and a call for future studies'. Together they form a unique fingerprint.

  • Cite this